70
J. Kondo et al. / Journal of Molecular Catalysis A: Chemical 395 (2014) 66–71
there would be significant steric repulsion between the side-arm
on the NHC ring and phenyl substituent of chalcone. Consequently,
the ACA reaction would be expected to proceed via reaction model
A to produce (S)-1,4-adduct.
(OCH2CH3), 55.2 (CH2CO), 48.4 (NHCH), 14.0 (OCH2CH3). Anal. Calc.
for C21H29ClN4O8·1.2H2O: C, 48.27; H, 6.06; N, 10.72. Found: C,
48.00; H, 5.75; N, 10.82%.
4.2.2. Compound L5
White solid. mp 190.8–192.9 ◦C. 1H NMR ((CD3)2SO): ı 9.84 (s,
1H, CHbenzimid), 9.38 (br, 2H, NH), 7.90–7.87 (m, 2H, CHbenzimid),
7.70–7.68 (m, 2H, CHbenzimid), 5.54 (d, J = 16.5 Hz, 2H, CH2CO), 5.46
(d, J = 16.5 Hz, 2H, CH2CO), 4.32–4.26 (m, 2H, NHCH), 3.60 (s, 6H,
3. Conclusion
We demonstrated that
a C2-symmetric bis(ester-amide)-
functionalized azolium salt efficiently performs the copper-
catalyzed ACA of dialkylzinc reagents to acyclic or cyclic enones, with
up to 93% ee. These air-stable, chiral ligands are particularly use-
ful because of their easy preparation. In addition, the asymmetric
catalytic reaction was carried out at ambient temperature without
controlling the temperature of the reaction mixture. We believe the
preset catalytic system provides an alternative method for catalytic
ACA reaction.
i
OCH3), 1.75–1.51 (m, 6H, CH2CH Bu), 0.91 (d, J = 6.4 Hz, 6H, CH3
iBu), 0.84 (d, J = 6.4 Hz, 6H, CH3 iBu). 13C NMR: ı 172.3 (CO), 164.8
(CO), 144.3, 131.1, 126.7, 113.6, 52.0 (CH2CO), 50.8 (CH3O), 48.3
(NHCH), 24.2 (CH iBu), 22.7 (CH2 iBu), 21.2 (CH3 iBu). Anal. Calc. for
C
26H39ClN4O6·2.2H2O: C, 53.96; H, 7.56; N, 9.68. Found: C, 53.56;
H, 6.67; N, 10.11%.
4.2.3. Compound L6
White solid. mp 169.6–170.5 ◦C. 1H NMR ((CD3)2SO): ı 9.88 (s,
1H, CHbenzimid), 9.21 (br, 2H, NH), 7.93–7.91 (m, 2H, CHbenzimid),
7.69–7.67 (m, 2H, CHbenzimid), 5.65 (d, J = 16.5 Hz, 2H, CH2CO), 5.55
(d, J = 16.5 Hz, 2H, CH2CO), 4.14 (d, J = 8.2 Hz, 2H, NHCH), 3.61 (s, 6H,
OCH3), 0.99 (s, 18H, CH3 tBu). 13C NMR: ı 170.9 (CO), 165.0 (CO),
144.3, 131.1, 126.7, 113.5, 61.2 (CH2CO), 51.5 (CH3O), 48.3 (NHCH),
33.7 (C tBu), 26.5 (CH3 tBu). Anal. Calc. for C26H39ClN4O6·2H2O: C,
54.30; H, 7.54; N, 9.74. Found: C, 54.16; H, 7.21; N, 9.82%.
4. Experimental
4.1. General procedures
All chemicals were obtained from commercial sources and were
used as received. 1H and 13C NMR spectra were recorded on spec-
trometers at 400 and 100 MHz, respectively. Chemical shifts were
reported in ppm relative to TMS for 1H and 13C NMR spectra. CDCl3,
CD3OD, and (CD3)2SO were used as the NMR solvent. Thin-layer
chromatography (TLC) analysis was performed with glass-backed
plates pre-coated with silica gel and examined under UV (254 nm)
irradiation. Flash column chromatography was executed on silica
gel 60 (230–400; particle size: 0.040–0.063 nm).
4.3. General procedure for Cu-catalyzed asymmetric reaction of
enone with Et2Zn
To a solution of azolium salt (0.045 mmol) in THF (9 mL) were
added Cu(NO3)2·5H2O (0.050 mmol) and enone (1 mmol). After the
mixture was cooled to 0 ◦C, Et2Zn (3 mmol, 1 mol/L in hexanes,
3 mL) was added to the reaction vessel. The color immediately
changed from yellow to dark brown. After stirring at room tem-
perature for 3 h, the reaction was quenched with 10% HCl aq. The
resulting mixture was extracted with diisopropyl ether (3 × 10 mL)
and dried over Na2SO4. The product was purified by silica gel col-
umn chromatography (hexane/Et2O). The enantiomeric excess was
measured by the chiral GLC or chiral LC (See Appendix A. Supple-
mentary data).
4.2. General procedure for preparation of azolium salt
To CH3CN (8 mL) were added KOH (5.9 mmol, 331 mg), benzimi-
dazole (3) (3.7 mmol, 437 mg) and ␣-bromoacetamide derivative 1
(3.7 mmol, 888 mg) derived from bromoacetyl bromide and serine
methyl ester. After stirring the reaction mixture at room temper-
ature for 16 h, H2O was added to form a white precipitate. The
white product was separated from the solution by filtration under
reduced pressure, and then the solid was dissolved in methanol.
The resulting solution was dried over Na2SO4. After filtration, the
filtrate was concentrated under reduced pressure to obtain the
desired product such as substituted benzimidazole derivative 4.
The product 4 could be used without further purification in the
next step. Then, to 1,4-dioxane (15 mL) were added 4 (0.5 mmol,
139 mg) and ␣-chloroacetamide 2 (0.5 mmol, 98 mg) derived from
chloroacetyl chloride and serine methyl ester. After stirring the
reaction mixture at 110 ◦C for 2 days, the solvent was removed
under reduced pressure. The residue was dissolved in methanol,
methanol in vacuo from the filtrate, the crude residue was puri-
fied by column chromatography (SiO2, CH2Cl2/MeOH = 9/1) to yield
the corresponding azolium salt L1. Compound L1 [10b], L3 [9d], L4
[9d] and L7 [10a] were reported previously (See Supporting infor-
mation).
Acknowledgment
This work was financially supported by a Grant-in-Aid for Scien-
tific Research (C) (23550128) from Japan Society for the Promotion
of Science (JSPS).
Appendix A. Supplementary data
References
4.2.1. Compound L2
White solid. mp 189.0–192.4 ◦C. 1H NMR ((CD3)2SO): ı 9.38
(s, 1H, CHbenzimid), 9.24 (d, J = 7.3 Hz, 2H, NH), 7.91–7.89 (m, 2H,
CHbenzimid), 7.70–7.67 (m, 2H, CHbenzimid), 5.48 (s, 4H, NCH2CO),
5.31–5.29 (m, 2H, OH), 4.37–4.33 (m, 2H, NHCH), 4.11–4.05
(m, 4H, OCH2CH3), 3.80–3.75 (m, 2H, CH2OH), 3.71–3.66 (m,
2H, CH2OH), 1.15 (t, J = 7.1 Hz, 6H, CH2CH3). 13C NMR: ı 169.9
(CO), 164.8 (CO), 144.3, 131.1, 126.7, 113.6, 61.0 (CH2OH), 60.7